Abstract
Nest-building, a behavioral model shown to be disrupted by hallucinogens, has never been used to answer questions concerning the psychotomimetic effects of Δ 9-THC. Several fractions of cannabis and tobacco pyrolysis products were tested consecutively in the same procedure. The following drugs were injected i.p. under a saline-drug-saline schedule: d-amphetamine (6 mg/kg), pentobarbital (25 mg/kg), Δ 9-THC (10 mg/kg, 5 mg/kg, 2.5 mg/kg), the cannabis fractions designated Is (water soluble products), IIs (nonsoluble, nonvolatile products), IIIs (it comprises what is inhaled by a common hashish smoker), and analogous fractions of tobacco pyrolysis products designated IIIB (what is inhaled by a common tobacco smoker), IIB and IB.
The effects of Δ 9-THC (10 mg/kg), IIs, and IIIs were quite similar as far as the disruption of the normal behavioral pattern is concerned. d-Amphetamine, Δ 9-THC (5 mg/kg), and IIB disrupted the normal behavioral pattern as well. The similarity of the effects of IIs and IIIs was unexpected in view of the different contents of cannabinoids in these fractions. Also unexpected was the similarity of the effects of Δ 9-THC (10 mg/kg) and IIIs (40 mg/kg containing 7% Δ 9-THC) as well as the activity of fraction IIIB.
Similar content being viewed by others
References
Hollister, L. E., Gillespie, H.: Interactions in man of Δ 9-THC. II. CBN and CBD. Clin. Pharmacol. Ther. 18, 80–83 (1975)
Isbell, H., Gorodetzsky, G. W., Jasinski, D., Claussen, K., Spulak, F. V., Korte, F.: Effects of (−)Δ 9-trans-treahydrocannabinol in man. Psychopharmacologia (Berl.) 2, 184–188 (1967)
Karniol, I. G., Carlini, E. A.: The content of Δ 9-THC does not explain all biological activity of some Brazilian marihuana samples. J. Pharm. Pharmacol. 24, 833–834 (1972)
Karniol, I. G., Carlini, E. A.: Pharmacological interaction between CBD and Δ 9-THC. Psychopharmacologia (Berl.) 33, 53–70 (1973)
Karniol, I. G., Shirakawa, I., Kasinski, N., Preferman, A., Carlini, E. A.: CBD interferes with the effects of 183-5 in man. Eur. J. Pharmacol. 28, 172–177 (1974)
Kephalas, T. A., Kibouris, J., Michael, C. M., Miras, C. J., Papadakis, D. P.: Some aspects of cannabis smoke chemistry. In: Marijuana, Satellite Symposium of the 6th International Congress of Pharmacology, Helsinki, Finland, July 1975. Berlin: Springer (in press) 1977
Paton, W., Pertwee, R.: The pharmacology of cannabis in animals. In: Marijuana (R. Mechoulam, ed.) London: Academic Press 1973a
Paton, W., Pertwee, R.: The pharmacology of cannabis in man. In: Marijuana (R. Mechoulam, ed.) London: Academic Press 1973b
Savaki, H. E., Cunha, J., Carlini, E. A., Kephalas, T. A.: Activité pharmacologique de trois fractions provenant de cannabis fumé dans un narguilé. Bull. Stupéfiants 28, 51–55 (1976)
Schneider, C. W., Chenoweth, M. B.: Effects of hallucinogenic and other drugs on the nest-building behaviour of mice. Nature 225, 1262–1263 (1970)
Smythies, U. R., Johnston, V. S., Bradley, R. J.: Behavioural models of psychosis. Br. J. Psychiatry 115, 55–68 (1969)
Teresa, M., Silva, A., Calil, H. M.: Screening hallucinogenic drugs: systematic study of three behavioural tests. Psychopharmacologia (Berl.) 42, 163–171 (1975)
Webster, C. C., Willinsky, M. C., Herring, B. S., Walters, G. C.: Effects of 1 Δ 1-tetrahydrocannabinol on temporally spaced responding and discriminated Sidman avoidance behavior in rats. Nature 232, 98–501 (1971)
Willinsky, M., Webster, C., Herring, B.: Effects of 1 Δ 1-THC on Sidman discriminated avoidance behavior in rats. Act. Nerv. Suppl. 16A, 34–38 (1974)
Zinberg, N. E., Weil, A. T.: The effect of marijuana on human beings. Addictions 26, 26–43 (1969)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moschovakis, A., Liakopoulos, D., Armaganidis, A. et al. Cannabis interferes with nest-building behavior in mice. Psychopharmacology 58, 181–183 (1978). https://doi.org/10.1007/BF00426904
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00426904